Abbott Laboratories

News across the web »
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

107998 Followers

Firstpost

Platinum Member

231 Followers

Related News »
SmarTrend identified an Uptrend for Abbott Laboratories (NYSE:ABT) on August 17th, 2011 at $50.07. In approximately 9 months, Abbott Laboratories has returned 25.32% as of today's recent price of $62.75. In the past 52 weeks, Abbott Laboratories share ...
May 25, 2012 at 14:30 | Source: Comtex Smartrend
Abbott Laboratories (ABT) (ABT)’ bid to expand use of its best-selling arthritis treatment Humira to ulcerative colitis patients is being delayed by U.S. regulators. “We did receive a complete response letter several months ago and have ...
May 21, 2012 at 23:54 | Source: Businessweek
Abbott Laboratories (NYSE:ABT) has encountered a delay in its bid for U.S. regulatory approval to expand the uses of its blockbuster anti-inflammatory drug Humira to include treatment of the bowel disease ulcerative colitis. Abbott received a ...
May 22, 2012 at 16:43 | Source: Marketwatch
Analysts have spotted a possible bullish harami candle pattern in Abbott Laboratories (NYSE:ABT) based on the price action in the company's shares. Yesterday's real body is within Friday's body and may imply that traders and investors believe that the ...
May 22, 2012 at 11:06 | Source: Financial News Network Online
Friday, May 18, 2012... Abbott Laboratories (NYSE: ABT) closed Thursday's trading session at $62.23. In the past year, the stock has hit a 52-week low of $46.29 and 52-week..... Wednesday, May 16, 2012... Closing out the day... After a positive start ...
May 24, 2012 at 12:01 | Source: Market Intelligence Center
(RTTNews) - Abbott Laboratories (ABT: News ) Wednesday announced that it has introduced PediaSure SideKicks Clear, a refreshing clear nutritional beverage that helps balance out the diet of those picky eaters who are growing fine, but still may be missing ...
May 16, 2012 at 13:37 | Source: RTT News
Analyzing the price chart for Abbott Laboratories (NYSE:ABT) has revealed a potential bullish inside day candle pattern. Yesterday's price range of $61.60 and $62.15 is within the prior day's high and low of the day. This trading action often signifies ...
May 22, 2012 at 11:57 | Source: Financial News Network Online
May 18, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Abbott Laboratories (NYSE:ABT) on August 17th, 2011 at $50.07. In approximately 9 months, Abbott Laboratories has returned 23.97% as of today's recent price ...
May 18, 2012 at 14:39 | Source: TMCnet
Shares of Abbott Laboratories (NYSE:ABT) opened today above their pivot of $61.87 and have already reached the first level of resistance at $62.12. Should the shares continue to rise, the resistance pivots of $62.34 and $62.82 will be of interest.
May 16, 2012 at 14:55 | Source: Comtex Smartrend
No new colitis indication for Abbott Laboratories' ($ABT) Humira--yet. The FDA has asked for more information from Abbott, postponing its decision on the new indication for several more months. With 500,000 patients in the U.S., ulcerative ...
May 22, 2012 at 23:52 | Source: FiercePharma